Chang-Xin Shi
- Molecular Biology top 5%
- Hematology top 0.5%
- Oncology top 5%
- Pathology and Forensic Medicine top 10%
- Cancer Research
- Co-authors
- Esteban BraggioA. Keith StewartP. Leif BergsagelJessica SchmidtLaura A. BruinsRafaël FonsecaYuan Xiao ZhuXiu-Bao Chang
- Topics
- Multiple Myeloma Research and Treatments (16 papers)Protein Degradation and Inhibitors (14 papers)Ubiquitin and proteasome pathways (6 papers)
- Cited by
- HematologyMolecular BiologyOncology
- Journals
- BloodPLoS ONEBiochemistry
- Partner nations
- United StatesCanadaChina
In The Last Decade
Chang-Xin Shi
20 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 1.4k
- Hematology 1.1k
- Oncology 490
- Pathology and Forensic Medicine 147
- Cancer Research 131
Countries citing papers authored by Chang-Xin Shi
This map shows the geographic impact of Chang-Xin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang-Xin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang-Xin Shi more than expected).
Fields of papers citing papers by Chang-Xin Shi
This network shows the impact of papers produced by Chang-Xin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang-Xin Shi. The network helps show where Chang-Xin Shi may publish in the future.
Co-authorship network of co-authors of Chang-Xin Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Chang-Xin Shi. A scholar is included among the top collaborators of Chang-Xin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang-Xin Shi. Chang-Xin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 23 | |
| 3 | 70 | |
| 4 | 24 | |
| 5 | 10 | |
| 6 | 42 | |
| 7 | 53 | |
| 8 | 72 | |
| 9 | 35 | |
| 10 | 31 | |
| 11 | 55 | |
| 12 | 15 | |
| 13 | 18 | |
| 14 | 170 | |
| 15 | 85 | |
| 16 | 286 | |
| 17 | 81 | |
| 18 | Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomidebreakdown → | 461 |
| 19 | 83 | |
| 20 | 44 |
About Chang-Xin Shi
Chang-Xin Shi is a scholar working on Hematology, Molecular Biology and Oncology, having authored 20 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (14 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Hematology (1.1k citations), Molecular Biology (1.4k citations) and Oncology (490 citations). Chang-Xin Shi has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Esteban Braggio, A. Keith Stewart, P. Leif Bergsagel, Jessica Schmidt, Laura A. Bruins, Rafaël Fonseca, Yuan Xiao Zhu, Xiu-Bao Chang, Scott Van Wier and Chad C. Bjorklund. Their work appears in journals such as Blood, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.